245 related articles for article (PubMed ID: 23980106)
41. The modA10 phasevarion of nontypeable Haemophilus influenzae R2866 regulates multiple virulence-associated traits.
VanWagoner TM; Atack JM; Nelson KL; Smith HK; Fox KL; Jennings MP; Stull TL; Smith AL
Microb Pathog; 2016 Mar; 92():60-67. PubMed ID: 26718097
[TBL] [Abstract][Full Text] [Related]
42. Sap transporter mediated import and subsequent degradation of antimicrobial peptides in Haemophilus.
Shelton CL; Raffel FK; Beatty WL; Johnson SM; Mason KM
PLoS Pathog; 2011 Nov; 7(11):e1002360. PubMed ID: 22072973
[TBL] [Abstract][Full Text] [Related]
43. Resveratrol therapeutics combines both antimicrobial and immunomodulatory properties against respiratory infection by nontypeable Haemophilus influenzae.
Euba B; López-López N; Rodríguez-Arce I; Fernández-Calvet A; Barberán M; Caturla N; Martí S; Díez-Martínez R; Garmendia J
Sci Rep; 2017 Oct; 7(1):12860. PubMed ID: 29038519
[TBL] [Abstract][Full Text] [Related]
44. Expression of cytokine and chemokine genes by human middle ear epithelial cells induced by formalin-killed Haemophilus influenzae or its lipooligosaccharide htrB and rfaD mutants.
Tong HH; Chen Y; James M; Van Deusen J; Welling DB; DeMaria TF
Infect Immun; 2001 Jun; 69(6):3678-84. PubMed ID: 11349030
[TBL] [Abstract][Full Text] [Related]
45. The roles of epithelial cell contact, respiratory bacterial interactions and phosphorylcholine in promoting biofilm formation by Streptococcus pneumoniae and nontypeable Haemophilus influenzae.
Krishnamurthy A; Kyd J
Microbes Infect; 2014 Aug; 16(8):640-7. PubMed ID: 24998491
[TBL] [Abstract][Full Text] [Related]
46. Biofilms formed by nontypeable Haemophilus influenzae in vivo contain both double-stranded DNA and type IV pilin protein.
Jurcisek JA; Bakaletz LO
J Bacteriol; 2007 May; 189(10):3868-75. PubMed ID: 17322318
[TBL] [Abstract][Full Text] [Related]
47. Duplicate copies of lic1 direct the addition of multiple phosphocholine residues in the lipopolysaccharide of Haemophilus influenzae.
Fox KL; Li J; Schweda EK; Vitiazeva V; Makepeace K; Jennings MP; Moxon ER; Hood DW
Infect Immun; 2008 Feb; 76(2):588-600. PubMed ID: 17984210
[TBL] [Abstract][Full Text] [Related]
48. Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates.
Hou Y; Gu XX
J Immunol; 2003 Apr; 170(8):4373-9. PubMed ID: 12682274
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of phase variation of nontypeable Haemophilus influenzae lipooligosaccharide during nasopharyngeal colonization and development of otitis media in the chinchilla model.
Tong HH; Blue LE; James MA; Chen YP; DeMaria TF
Infect Immun; 2000 Aug; 68(8):4593-7. PubMed ID: 10899860
[TBL] [Abstract][Full Text] [Related]
50. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
[TBL] [Abstract][Full Text] [Related]
51. Effect of mutations in lipooligosaccharide biosynthesis genes on virulence of Haemophilus influenzae type b.
Cope LD; Yogev R; Mertsola J; Argyle JC; McCracken GH; Hansen EJ
Infect Immun; 1990 Jul; 58(7):2343-51. PubMed ID: 1694825
[TBL] [Abstract][Full Text] [Related]
52. Effect of lipooligosaccharide mutations of Haemophilus influenzae on the middle and inner ears.
Schachern PA; Tsuprun V; Wang B; Apicella MA; Cureoglu S; Paparella MM; Juhn SK
Int J Pediatr Otorhinolaryngol; 2009 Dec; 73(12):1757-60. PubMed ID: 19853312
[TBL] [Abstract][Full Text] [Related]
53. The structural heterogeneity of the lipooligosaccharide (LOS) expressed by pathogenic non-typeable Haemophilus influenzae strain NTHi 9274.
Rahman MM; Gu XX; Tsai CM; Kolli VS; Carlson RW
Glycobiology; 1999 Dec; 9(12):1371-80. PubMed ID: 10561462
[TBL] [Abstract][Full Text] [Related]
54. Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274.
Ueyama T; Gu XX; Tsai CM; Karpas AB; Lim DJ
Clin Diagn Lab Immunol; 1999 Jan; 6(1):96-100. PubMed ID: 9874671
[TBL] [Abstract][Full Text] [Related]
55. The adhesins of non-typeable Haemophilus influenzae.
Osman KL; Jefferies JM; Woelk CH; Cleary DW; Clarke SC
Expert Rev Anti Infect Ther; 2018 Mar; 16(3):187-196. PubMed ID: 29415569
[TBL] [Abstract][Full Text] [Related]
56. Relationship between azithromycin susceptibility and administration efficacy for nontypeable Haemophilus influenzae respiratory infection.
Euba B; Moleres J; Viadas C; Barberán M; Caballero L; Grilló MJ; Bengoechea JA; de-Torres JP; Liñares J; Leiva J; Garmendia J
Antimicrob Agents Chemother; 2015 May; 59(5):2700-12. PubMed ID: 25712355
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of genetic differences in phosphorylcholine expression between nontypeable Haemophilus influenzae and Haemophilus haemolyticus.
McCrea KW; Xie J; Marrs CF; Gilsdorf JR
BMC Microbiol; 2010 Nov; 10():286. PubMed ID: 21073698
[TBL] [Abstract][Full Text] [Related]
58. A chalcone with potent inhibiting activity against biofilm formation by nontypeable Haemophilus influenzae.
Kunthalert D; Baothong S; Khetkam P; Chokchaisiri S; Suksamrarn A
Microbiol Immunol; 2014 Oct; 58(10):581-9. PubMed ID: 25154700
[TBL] [Abstract][Full Text] [Related]
59. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
[TBL] [Abstract][Full Text] [Related]
60. Haemophilus influenzae biofilms: hypothesis or fact?
Moxon ER; Sweetman WA; Deadman ME; Ferguson DJ; Hood DW
Trends Microbiol; 2008 Mar; 16(3):95-100. PubMed ID: 18280163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
